The Siemens-Elema Servo Ventilator 900 B for the management of newborn infants with severe respiratory distress syndrome: a 22-month trial

Critical Care Medicine
D J RawlingsT R Thompson


The Siemens-Elema Servo Ventilator 900 B is an electronically-controlled, volume-limited ventilator. To adapt this ventilator for use in newborns with respiratory failure, minute volume control, PEEP valves, air-oxygen blenders, and respiratory tubing circuits were modified. During a 22-month period, 161 newborn infants with severe respiratory distress syndrome (RDS) were managed with this ventilator. The overall survival rate was 66%; the incidence of barotrauma was 20%; the survival rate was 53%. Of the infants studied, 12% developed bronchopulmonary dysplasia, and 79% of these survived. Of the 19% of patients with a symptomatic intraventricular hemorrhage, 6% survived. The experience of the authors with this ventilator modified to manage newborn infants with severe RDS has been extremely encouraging. Furthermore, this ventilator is versatile because it can be readily recalibrated for use in older patients and can be easily adapted for patients requiring surgery. This ventilator has the extremely important advantage of being a volume ventilator which can effectively provide positive pressure ventilatory support to patients of all age and weight groups.

Related Concepts

Clinical Trials
Ventilator - Respiratory Equipment
Respiratory Distress Syndrome, Newborn

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Lipidomics & Rhinovirus Infection

Lipidomics can be used to examine the lipid species involved with pathogenic conditions, such as viral associated inflammation. Discovered the latest research on Lipidomics & Rhinovirus Infection.

Alzheimer's Disease: MS4A

Variants within the membrane-spanning 4-domains subfamily A (MS4A) gene cluster have recently been implicated in Alzheimer's disease in genome-wide association studies. Here is the latest research on Alzheimer's disease and MS4A.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Torsion Dystonia

Torsion dystonia is a movement disorder characterized by loss of control of voluntary movements appearing as sustained muscle contractions and/or abnormal postures. Here is the latest research.

Generating Insulin-Secreting Cells

Reprogramming cells or using induced pluripotent stem cells to generate insulin-secreting cells has significant therapeutic implications for diabetics. Here is the latest research on generation of insulin-secreting cells.

Central Pontine Myelinolysis

Central Pontine Myelinolysis is a neurologic disorder caused most frequently by rapid correction of hyponatremia and is characterized by demyelination that affects the central portion of the base of the pons. Here is the latest research on this disease.

Epigenome Editing

Epigenome editing is the directed modification of epigenetic marks on chromatin at specified loci. This tool has many applications in research as well as in the clinic. Find the latest research on epigenome editing here.

Related Papers

American Journal of Critical Care : an Official Publication, American Association of Critical-Care Nurses
K J VacaM T Swartz
© 2021 Meta ULC. All rights reserved